Results 171 to 180 of about 12,070 (302)

Covering Up for Coworkers: A Scale Development and Empirical Examination of Relational Cover‐Up Behavior

Journal of Organizational Behavior, EarlyView.
ABSTRACT Why do employees conceal their coworkers' unethical behavior and who is most likely to do so? To address these questions, we begin by developing and validating a psychometrically robust measure of relational cover‐up behavior (Study 1). Using a two‐wave study (N = 475), we then test the argument that employees may experience an identity threat
Jenny H. Wang, Annika Hillebrandt, Laurie J. Barclay   +2 more
wiley   +1 more source

Toward Faster Recalls of Dangerous Medical Devices: Does Ownership by Large Institutional Investors Matter?

Journal of Operations Management, EarlyView.
ABSTRACT Recall delays expose consumers to prolonged risk and undermine a firm's long‐term performance and reputation. Building on agency theory's conceptualization of principal‐agent relationships, we theorize that large institutional investors play an important monitoring role wherein their ownership encourages faster recalls. We then build on agency
Jessica L. Darby, Kaitlin D. Wowak, David J. Ketchen Jr., Brian L. Connelly   +3 more
wiley   +1 more source

Revisiting Vincristine for FSGS: Proof-of-Mechanism Arrives, but Whom Should We Treat? [PDF]

Kidney Int Rep
Guo W, Luo J, Li Z, Li X, Zhang Y, Yang J.   +5 more
europepmc   +1 more source

European Society for Paediatric Gastroenterology, Hepatology and Nutrition/North American Society for Pediatric Gastroenterology, Hepatology and Nutrition guidelines for treatment of functional constipation in children aged 0–18 years

Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Functional constipation (FC) is common in childhood, significantly impacting quality of life. Since the 2014 international guideline, new evidence has been published, and methods on making guidelines have developed. This treatment guideline for FC in children aged 0–18 years is a collaborative effort of the European and North ...
Morris Gordon, Anna de Geus, Mary Boruta, Marcin Banasiuk, Marc Benninga, Osvaldo Borrelli, Anil Darbari, Dawn Dore‐Stites, Michelle Gould, Juliette Hawa, Kirsten Jones, Alexandra Kilgore, Hayat Mousa, Samuel Nurko, Nikhil Thapar, Julie Khlevner, Vasiliki Sinopoulou, Merit Tabbers   +17 more
wiley   +1 more source

Striving to Provide Reliable and Trusted Sources of Research Evidence in Support of Musculoskeletal Clinical Practice and Education. [PDF]

HSS J
Cornell CN.
europepmc   +1 more source

Unlocking Business Success: How Networking and Branding Capabilities Drive Performance Through Product Innovativeness

Strategic Change, EarlyView.
ABSTRACT In today's fast‐paced market, developing innovative products with significant advantages over existing alternatives is essential for a strong market presence. This study, based on the resource‐based and dynamic capability view, examines how market and technological innovativeness contribute to differentiation advantage and improved business ...
Farbod Fakhreddin, Pantea Foroudi
wiley   +1 more source

Obstetric and Emergency Anesthesia in Somalia: Patient Safety Challenges in a Fragile Health System. [PDF]

Int J Womens Health
Mohamed IA.
europepmc   +1 more source

Toward Real‐World Learning. Insights From an Established Community‐Based Dental Education Program

Journal of Dental Education, EarlyView.
Avril Ware, Moaz M. Almoteb, Thomas A. Dyer   +2 more
wiley   +1 more source

Failure in Motion: A Framework for Capability Erosion and Institutional Dysfunction

Strategic Change, EarlyView.
ABSTRACT Drawing on the literature on capability erosion and institutional dysfunction (ID), this study develops a conceptual framework that sheds new light on how the interaction between capability erosion and ID creates conditions for business failure across borders. By articulating two dimensions of heterogeneous capability and resource erosion (i.e.
Joseph Amankwah‐Amoah, Ahmed Adel Tantawy   +1 more
wiley   +1 more source

When herds overgraze: the cost of conformity in oncology drug development. [PDF]

BMJ Oncol
Liu J, LoRusso P.
europepmc   +1 more source